Chewing tobacco

Chewing tobacco
Name	Chewing tobacco
Type	Smokeless tobacco product
Origin	Indigenous American cultivation and later colonial trade
Regions	Worldwide use, notable in North America, South Asia, Scandinavia

Chewing tobacco is a smokeless tobacco product made from dried and fermented leaves of the Tobacco plant that users place between the cheek and gum or chew. It has played roles in cultural practices, trade networks, and public health debates involving figures such as Benjamin Franklin, Queen Elizabeth I, George Washington, Abraham Lincoln, and institutions like the Royal College of Physicians and the World Health Organization. Production, distribution, and control intersect with historical actors including Christopher Columbus, John Rolfe, Jamestown, East India Company, British Empire, Spanish Empire, and modern regulators like the Food and Drug Administration and the European Commission.

History

Chewing tobacco's antecedents trace to Indigenous American practices documented by explorers such as Hernán Cortés and observers accompanying Christopher Columbus; colonial expansion and plantations in places like Jamestown and Virginia (colony) integrated tobacco into commodity chains linked to the Transatlantic slave trade and companies such as the East India Company. Prominent colonial and early republic figures including John Rolfe, Benjamin Franklin, George Washington, and Thomas Jefferson appear in archival accounts tied to cultivation, commerce, and consumption. During the 19th century, chewing tobacco featured in popular culture alongside entertainers like Mark Twain and baseball players associated with the National League (formed 1876); it also intersected with industrialists such as John D. Rockefeller and policy debates in legislatures like the United States Congress and ministries of the United Kingdom. Twentieth-century scrutiny from public health institutions—Royal College of Physicians, Centers for Disease Control and Prevention, World Health Organization—and landmark events like the 1964 Surgeon General's report reframed chewing tobacco within discourses of morbidity and regulation driven by entities such as the Food and Drug Administration and international treaties exemplified by the WHO Framework Convention on Tobacco Control.

Types and Composition

Varieties include manufactured formats produced by firms like U.S. Smokeless Tobacco Company and regional artisanal forms linked to local producers; notable product classes mirror categorizations used by agencies such as the Centers for Disease Control and Prevention and the European Medicines Agency. Major types historically and contemporaneously comprise loose leaf, plug, twist, and modern pouch forms, paralleling product evolution seen in markets associated with corporations like Altria and brands referenced alongside retailers such as Walgreens and Walmart (company). Chemical composition involves alkaloids derived from Nicotiana tabacum and Nicotiana rustica, with nicotine levels assessed in analytical studies from laboratories at institutions such as Johns Hopkins University, Harvard School of Public Health, and Mayo Clinic. Additives, curing methods, and fermentation practices employed by manufacturers reflect technologies profiled by research groups at Massachusetts Institute of Technology, University of California, San Francisco, and Imperial College London.

Production and Regulation

Cultivation, curing, and processing occur on farms and in facilities historically linked to agricultural regions like Virginia (U.S. state), Kentucky, Tobacco Belt, and international growers in India and Brazil. Companies engaged in production include multinational corporations with ties to Philip Morris International, British American Tobacco, and regional producers regulated by national agencies such as the Food and Drug Administration, European Commission, and Ministry of Health and Family Welfare (India). Regulatory frameworks evolve through legislation and litigation involving courts such as the Supreme Court of the United States, policy actions by the United States Congress, and international agreements like the WHO Framework Convention on Tobacco Control. Market forces and taxation policies interact with retail channels exemplified by chains such as 7-Eleven and regulatory compliance monitored by bodies like the Federal Trade Commission.

Health Effects and Risks

Public health research from institutions including the World Health Organization, Centers for Disease Control and Prevention, National Cancer Institute, Royal College of Physicians, Mayo Clinic, Johns Hopkins University, and Harvard School of Public Health documents links between chewing tobacco use and increased risks of oral cancers, periodontal disease, cardiovascular disease, and nicotine dependence. Epidemiological studies produced in collaboration with centers such as National Institutes of Health, University of California, Los Angeles, and Karolinska Institutet quantify morbidity and mortality burdens; clinical trials and cohort studies published in journals connected to The Lancet, New England Journal of Medicine, and JAMA (Journal of the American Medical Association) examine dose–response relationships and biomarkers measured by laboratories at Imperial College London and University of Oxford. Regulatory and advisory statements from the Surgeon General of the United States and rulings in courts such as the Supreme Court of the United States reflect contested evidence on product labeling, youth initiation, and harm reduction claims advanced by corporations like Altria and British American Tobacco.

Patterns of Use and Demographics

Use patterns vary by geography and population subgroups studied by universities such as University of Michigan, Columbia University, University of California, Berkeley, and public agencies including the Centers for Disease Control and Prevention and National Health Service (UK). Demographic analyses identify higher prevalence in rural communities of United States, among certain occupational groups such as agricultural laborers historically employed in Tobacco Belt regions, and in countries like India where regional customs intersect with brands distributed by firms operating in markets across South Asia. Surveillance systems and surveys administered by organizations such as the Behavioral Risk Factor Surveillance System, Global Adult Tobacco Survey, and national censuses inform policy debates in parliaments and ministries including the United States Congress and Ministry of Health and Family Welfare (India). Cultural depictions in media involving figures like Mark Twain, Babe Ruth, and institutions such as Major League Baseball shaped social norms around use.

Cessation and Treatment Approaches

Cessation strategies recommended by clinical guidelines from bodies like the American Cancer Society, National Institute for Health and Care Excellence, Centers for Disease Control and Prevention, and World Health Organization include behavioral counseling, pharmacotherapies (nicotine replacement therapy), and regulatory interventions exemplified by campaigns led by the Surgeon General of the United States and public health programs in agencies such as the National Health Service (UK). Research collaborations between institutions like Johns Hopkins University, Harvard Medical School, Mayo Clinic, and University of California, San Francisco evaluate interventions including counseling delivered through providers affiliated with hospitals such as Massachusetts General Hospital and community programs supported by foundations like the Bill & Melinda Gates Foundation. Legal actions and policy measures involving the Food and Drug Administration, Supreme Court of the United States, and international governance under the WHO Framework Convention on Tobacco Control influence access to cessation services, labeling, and youth prevention initiatives.

Category:Tobacco